Raz Yirmiya
msrazy@mscc.huji.ac.il
>Also, would you know of ongoing studies assessing IL-1ra in humans, alone or as an adjunct, in treating depression?
Dear Hymie,
Thanks for your interest in the paper. The dose of endotoxin that we used (0.8 ng/kg) produced mild 
symptoms of overt illness, including low fever (0.5-1 degree), cortisol elevation and mild 
headache and muscle pain (mainly at 2, but not at 4 or  9 hr post-injection). 
Thus, some of the psychological findings seem to be dissociated from 
the clinical symptoms.
I do not know of any experiment with IL-1ra in depressed patients. I discussed this idea with  Steve Maier a few years ago, 
but so far nothing came out of it. I should emphasize that IL-1ra by itself may not be an effective antidepressant since if 
there is some source of immune/stress-like cytokinergic activation in depressed patients it 
is probably mediated by several cytokines in addition to IL-1. As you show in your 
research, and as we find in our recent studies, cytokines probably act in a synergistic and 
complementary manner. Thus, compounds with a more general cytokine-suppressing 
activity may be needed to alleviate immune-associated depression.